These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of low molecular weight heparin on pancreatic micro-circulation in severe acute pancreatitis in a rodent model. Qiu F; Lü XS; Huang YK Chin Med J (Engl); 2007 Dec; 120(24):2260-3. PubMed ID: 18167214 [TBL] [Abstract][Full Text] [Related]
4. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Deepa PR; Varalakshmi P Toxicology; 2006 Jan; 217(2-3):176-83. PubMed ID: 16242830 [TBL] [Abstract][Full Text] [Related]
6. [Effects of low molecular weight heparin on the inflammatory response and vascular injury in rat after electric burn]. Jiang N; Xie W; Wang H; Jin D; Tan H; Zhao C Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):128-33. PubMed ID: 24989657 [TBL] [Abstract][Full Text] [Related]
7. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed. Blatný J; Fiamoli V Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852 [TBL] [Abstract][Full Text] [Related]
8. Prevention effect of orally active heparin derivative on deep vein thrombosis. Kim SK; Lee DY; Kim CY; Moon HT; Byun Y Thromb Haemost; 2006 Aug; 96(2):149-53. PubMed ID: 16894457 [TBL] [Abstract][Full Text] [Related]
9. Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Zhou J; May L; Liao P; Gross PL; Weitz JI Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):863-9. PubMed ID: 19265029 [TBL] [Abstract][Full Text] [Related]
11. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin. Moaveni DK; Lynch EM; Luke C; Sood V; Upchurch GR; Wakefield TW; Henke PK J Vasc Surg; 2008 Mar; 47(3):616-24. PubMed ID: 18295113 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects. Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174 [TBL] [Abstract][Full Text] [Related]
13. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood. Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406 [TBL] [Abstract][Full Text] [Related]
14. Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment. Deepa PR; Varalakshmi P Chem Biol Interact; 2005 Oct; 156(2-3):93-100. PubMed ID: 16154121 [TBL] [Abstract][Full Text] [Related]
15. A newly developed oral heparin derivative for deep vein thrombosis: non-human primate study. Kim SK; Lee DY; Kim CY; Nam JH; Moon HT; Byun Y J Control Release; 2007 Nov; 123(2):155-63. PubMed ID: 17884230 [TBL] [Abstract][Full Text] [Related]
16. Role of heparin on TNF-alpha and IL-6 levels in liver regeneration after partial hepatic resection. Yuceturk H; Yagmurdur MC; Gur G; Demirbilek M; Bilezikci B; Turan M; Karakayali H; Haberal M Eur Surg Res; 2007; 39(4):216-21. PubMed ID: 17438357 [TBL] [Abstract][Full Text] [Related]
17. Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative. Deepa PR; Varalakshmi P Int J Cardiol; 2006 Jan; 106(3):338-47. PubMed ID: 16337042 [TBL] [Abstract][Full Text] [Related]
18. Anti-thrombosis effect of LRRFIP1 shRNA lentivirus in a mouse model of deep vein thrombosis. Yin X; Wu S; Wang Z; Wang Y; Du Q; Wang A Thromb Res; 2013 Jul; 132(1):127-31. PubMed ID: 23751182 [TBL] [Abstract][Full Text] [Related]
19. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis. Henke PK; Varma MR; Moaveni DK; Dewyer NA; Moore AJ; Lynch EM; Longo C; Deatrick CB; Kunkel SL; Upchurch GR; Wakefield TW Thromb Haemost; 2007 Nov; 98(5):1045-55. PubMed ID: 18000610 [TBL] [Abstract][Full Text] [Related]
20. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis. Naz R; Naz S; Mehboob M; Khalid GH J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]